Evaluation of Patients With Invasive Breast Carcinoma Submitted to Neoadjuvant Chemotherapy Attended at Dr Arnaldo Vieira De Carvalho Cancer Institute Form 2006 to 2014

doi 10.29289/259453942019v29s1ep47
Full Text
Abstract

Available in full text

Date
Authors
Publisher

v29s1

Related search

Prognostic Evaluation of Patients With Luminal B Immunophenotype, Submitted to Neoadjuvant Chemotherapy Attended at Dr Arnaldo Vieira De Carvalho Cancer Institute From 2006 to 2014

2019English

HLA-DR in Cytotoxic T Lymphocytes Predicts Breast Cancer Patients' Response to Neoadjuvant Chemotherapy

Frontiers in Immunology
AllergyImmunology
2018English

Can Shear Wave Elastography Variables Predict the Pathological Response to Neoadjuvant Chemotherapy in Patients With Invasive Breast Cancer?

Ultrasound in Medicine and Biology
UltrasonicsRadiologyUltrasound TechnologyAcousticsNuclear MedicineBiophysicsRadiologicalImaging
2017English

MRP1 but Not MDR1 Is Associated With Response to Neoadjuvant Chemotherapy in Breast Cancer Patients

Disease Markers
BiochemistryMedicineClinical BiochemistryMolecular BiologyGenetics
2013English

Neoadjuvant Chemotherapy in Breast Cancer

English

Role of Magnetic Resonance Imaging in the Evaluation of Breast Cancer Response to Neoadjuvant Chemotherapy

In Vivo
BiochemistryMedicineGeneticsPharmacologyMolecular Biology
2020English

1830 Diagnosis of Pathological Complete Response to Neoadjuvant Chemotherapy in Breast Cancer by Minimal Invasive Biopsy Techniques

European Journal of Cancer
Cancer ResearchOncology
2015English

Evaluation of the Response of Breast Cancer Patients to Neoadjuvant Chemotherapy by Combined Contrast‑enhanced Ultrasonography and Ultrasound Elastography

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2019English

P53 Codon 72 Polymorphism Predicts the Pathologic Response to Neoadjuvant Chemotherapy in Patients With Breast Cancer

Clinical Cancer Research
Cancer ResearchOncology
2005English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy